GoodRx Holdings, Inc. (GDRX)
GoodRx Holdings, Inc. operates a leading price comparison platform for prescription drugs in the United States, offering consumers tools to save money on medications. The company also provides other healthcare services, including telehealth and pharma manufacturer solutions.
Company Overview
GoodRx Holdings, Inc. empowers consumers to make informed healthcare decisions by providing transparent prescription drug pricing and access to discounts, leveraging its extensive network and innovative platform to drive affordability and accessibility in the pharmaceutical market.
Investment Thesis
GoodRx presents a compelling investment opportunity due to its established market position and potential for continued growth in the healthcare information services sector. With a P/E ratio of 26.73 and a gross margin of 91.0%, the company demonstrates strong profitability and operational efficiency. The increasing demand for affordable healthcare solutions and prescription drug price transparency should drive user growth and subscription revenue. Key catalysts include the expansion of telehealth services and partnerships with pharmaceutical manufacturers. The company's beta of 1.50 suggests higher volatility than the market. The ongoing focus on innovation and strategic acquisitions could further solidify GoodRx's market leadership and enhance shareholder value.
Key Highlights
- Market Cap of $0.83B indicates a significant, yet still scalable, presence in the healthcare information services market.
- P/E ratio of 26.73 suggests investors are paying a premium for current earnings, reflecting expectations of future growth.
- Gross Margin of 91.0% highlights the company's efficient business model and strong pricing power.
- Profit Margin of 4.0% demonstrates the company's ability to convert revenue into profit, with potential for further improvement through operational efficiencies.
- Beta of 1.50 indicates the stock is more volatile than the market, potentially offering higher returns but also greater risk.
Competitors
Strengths
- Strong brand recognition and user base.
- Extensive network of pharmacy partnerships.
- Proprietary technology platform.
- High gross margins.
Weaknesses
- Reliance on pharmacy partnerships.
- Competition from other price comparison platforms.
- Potential regulatory changes affecting the pharmaceutical industry.
- Relatively low profit margin.
Catalysts
- Ongoing: Expansion of telehealth services to increase revenue streams.
- Ongoing: Partnerships with pharmaceutical manufacturers to improve medication adherence and offer discounts.
- Ongoing: Growth of subscription-based offerings to drive recurring revenue.
- Upcoming: Potential acquisitions of complementary businesses to expand service offerings.
Risks
- Potential: Increased competition from other price comparison platforms.
- Potential: Changes in pharmacy benefit manager (PBM) practices affecting revenue.
- Ongoing: Regulatory scrutiny of prescription drug pricing impacting business model.
- Potential: Economic downturn affecting consumer spending on healthcare.
- Ongoing: Reliance on maintaining strong relationships with pharmacy partners.
Growth Opportunities
- Expansion of Telehealth Services: GoodRx can leverage its existing user base to expand its telehealth offerings, providing convenient access to healthcare professionals and generating additional revenue streams. The telehealth market is projected to reach $278.5 billion by 2030, presenting a significant growth opportunity for GoodRx. By integrating telehealth services into its platform, GoodRx can enhance its value proposition and attract new users.
- Partnerships with Pharmaceutical Manufacturers: Collaborating with pharmaceutical manufacturers to offer discounts and improve medication adherence can drive revenue growth and strengthen GoodRx's position in the market. Pharma manufacturer solutions represent a significant growth area, allowing GoodRx to leverage its platform to connect manufacturers with patients and improve health outcomes. These partnerships can also provide GoodRx with exclusive access to discounts and promotions, further enhancing its value proposition.
- Subscription Model Expansion: Growing the subscription-based offerings, such as GoodRx Gold, can provide recurring revenue and increase customer loyalty. Subscriptions offer deeper discounts and additional benefits, attracting frequent users and driving long-term value. By expanding its subscription model, GoodRx can create a more predictable revenue stream and strengthen its relationship with its most valuable customers.
- Geographic Expansion: While primarily focused on the United States, GoodRx could explore opportunities to expand its services to other countries with similar healthcare challenges. International expansion could significantly increase GoodRx's addressable market and drive long-term growth. However, it would also require navigating different regulatory environments and healthcare systems.
- Data Analytics and Personalization: Leveraging data analytics to personalize the user experience and provide targeted recommendations can improve engagement and drive revenue growth. By analyzing user data, GoodRx can identify individual needs and preferences, providing tailored discounts and healthcare solutions. This personalized approach can enhance user satisfaction and increase the likelihood of repeat usage.
Opportunities
- Expansion of telehealth services.
- Partnerships with pharmaceutical manufacturers.
- Growth of subscription-based offerings.
- Geographic expansion.
Threats
- Increased competition from established players and new entrants.
- Changes in pharmacy benefit manager (PBM) practices.
- Regulatory scrutiny of prescription drug pricing.
- Economic downturn affecting consumer spending on healthcare.
Competitive Advantages
- Brand recognition and trust among consumers.
- Extensive network of pharmacy partnerships.
- Proprietary technology platform for price comparison.
- Large user base and data analytics capabilities.
About
GoodRx Holdings, Inc., founded in 2015 and headquartered in Santa Monica, California, has rapidly become a pivotal player in the healthcare information services sector. The company's core offering is a price comparison platform that allows consumers to compare prescription drug prices across various pharmacies in the United States. This platform provides geographically relevant pricing information and access to negotiated prices through GoodRx codes, enabling users to save money on their prescriptions. Beyond its price comparison tool, GoodRx has expanded its services to include subscriptions, offering deeper discounts and additional benefits to frequent users. The company also provides pharma manufacturer solutions, helping pharmaceutical companies connect with patients and improve medication adherence. Further diversifying its offerings, GoodRx has ventured into telehealth services, providing convenient access to healthcare professionals. By serving both consumers and pharmacy benefit managers, GoodRx facilitates transparency and efficiency in prescription drug transactions, establishing itself as a key intermediary in the pharmaceutical ecosystem.
What They Do
- Provide a price comparison platform for prescription drugs.
- Offer geographically relevant prescription pricing information.
- Provide access to negotiated prices through GoodRx codes.
- Offer subscription services for deeper discounts.
- Provide telehealth services for convenient access to healthcare professionals.
- Offer pharma manufacturer solutions to connect pharmaceutical companies with patients.
- Serve pharmacy benefit managers to facilitate prescription transactions.
Business Model
- Generate revenue through advertising and partnerships with pharmacies.
- Earn subscription fees from GoodRx Gold and other subscription services.
- Receive fees from pharmaceutical manufacturers for connecting them with patients.
- Generate revenue from telehealth services.
FAQ
What does GoodRx Holdings, Inc. do?
GoodRx Holdings, Inc. operates a price comparison platform for prescription drugs in the United States. The company provides consumers with tools to compare prices and access negotiated discounts on prescriptions, helping them save money on their medications. In addition to its price comparison platform, GoodRx offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. By serving both consumers and pharmacy benefit managers, GoodRx facilitates transparency and efficiency in prescription drug transactions, aiming to make healthcare more affordable and accessible.
Is GDRX stock a good buy?
GDRX stock presents a mixed investment profile. The company's strong gross margin of 91.0% and established brand recognition are positive indicators. However, the relatively low profit margin of 4.0% and a market cap of $0.83B suggest potential limitations. The company's growth opportunities in telehealth and pharma partnerships could drive future value. Investors should consider the competitive landscape and regulatory risks before investing. A balanced analysis of valuation metrics, growth potential, and risk factors is essential to determine if GDRX is a suitable investment.
What are the main risks for GDRX?
The main risks for GoodRx include increased competition from other price comparison platforms, changes in pharmacy benefit manager (PBM) practices, and regulatory scrutiny of prescription drug pricing. The company's reliance on pharmacy partnerships also poses a risk, as changes in these relationships could impact revenue. Additionally, an economic downturn could affect consumer spending on healthcare, reducing demand for GoodRx's services. Investors should carefully consider these risks before investing in GDRX.
Industry Context
GoodRx operates within the rapidly evolving healthcare information services industry, driven by increasing consumer demand for transparency and affordability in prescription drug pricing. The market is characterized by a complex web of pharmacy benefit managers, pharmaceutical manufacturers, and pharmacies, creating opportunities for intermediaries like GoodRx to streamline the process and provide value to consumers. The industry is experiencing growth due to rising healthcare costs and the increasing adoption of digital health solutions. Competitors like AHCO, AMPH, COLL, CTEV, and HSTM are vying for market share, but GoodRx's established brand and extensive network provide a competitive edge.
Key Customers
- Consumers seeking affordable prescription drugs.
- Pharmacy benefit managers (PBMs).
- Pharmaceutical manufacturers.
- Pharmacies.
Financials
Recent Quarterly Results
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $196M | $1M | $0.00 |
| Q2 2025 | $203M | $13M | $0.00 |
| Q1 2025 | $203M | $11M | $0.00 |
| Q4 2024 | $199M | $7M | $0.00 |
Source: Company filings
Chart & Info
Price Chart
GoodRx Holdings, Inc. (GDRX) stock price: $2.83 (+0.08, +2.91%)
Why Bull
- •GoodRx has seen recent insider buying, suggesting confidence in the company's future prospects.
- •Community sentiment has shifted positively, with discussions highlighting the increasing demand for affordable healthcare solutions.
- •The ongoing expansion of partnerships with pharmacies enhances its market position and accessibility for users.
- •Recent marketing campaigns have resonated well, leading to higher engagement and brand recognition among consumers.
Why Bear
- •Concerns over regulatory scrutiny in the healthcare sector may impact operational flexibility and growth.
- •Community discussions reflect skepticism regarding the sustainability of user growth amidst increasing competition.
- •Recent earnings reports have shown mixed results, leading to uncertainty about the company's profitability trajectory.
- •Market perception has been clouded by broader economic challenges, which could affect consumer spending on healthcare services.
Latest News
-
1 Healthcare Stock with Promising Prospects and 2 Facing Challenges
StockStory · Feb 11, 2026
-
1 Healthcare Stock with Promising Prospects and 2 Facing Challenges
Yahoo! Finance: GDRX News · Feb 11, 2026
-
How Recent Analyst Shifts Are Rewriting The Story For GoodRx Holdings (GDRX)
Yahoo! Finance: GDRX News · Feb 10, 2026
-
How Recent Analyst Shifts Are Rewriting The Story For GoodRx Holdings (GDRX)
Simply Wall St. · Feb 10, 2026
Technical Analysis
Rationale
AI-generated technical analysis for GDRX including trend direction, momentum, and pattern recognition.
What to Watch
Key support and resistance levels, volume signals, and upcoming events.
Risk Management
Position sizing, stop-loss levels, and risk-reward assessment.
Community
Discussion
Share your analysis and discuss GoodRx Holdings, Inc. (GDRX) with other investors. Log in to post.
Sentiment
Community sentiment and discussion activity for GDRX.
Make a Prediction
Set your price target for GoodRx Holdings, Inc. (GDRX), choose a timeframe, and track your prediction accuracy.
Current price: $2.83
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for GDRX.
Price Targets
Wall Street price target analysis for GDRX.
Insider Flow (30d)
MoonshotScore
Score Factors
- Revenue Growth 4/100
- Gross Margin 10/100
- Operating Leverage 4/100
- Cash Runway 8/100
- R&D Intensity 7/100
- Insider Activity 6/100
- Short Interest 10/100
- Price Momentum 0/100
- News Sentiment 5/100
What does this score mean?
The MoonshotScore rates GDRX's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Competitors & Peers
Latest News
1 Healthcare Stock with Promising Prospects and 2 Facing Challenges
1 Healthcare Stock with Promising Prospects and 2 Facing Challenges
How Recent Analyst Shifts Are Rewriting The Story For GoodRx Holdings (GDRX)
How Recent Analyst Shifts Are Rewriting The Story For GoodRx Holdings (GDRX)
Frequently Asked Questions
What does GoodRx Holdings, Inc. do?
GoodRx Holdings, Inc. operates a price comparison platform for prescription drugs in the United States. The company provides consumers with tools to compare prices and access negotiated discounts on prescriptions, helping them save money on their medications. In addition to its price comparison platform, GoodRx offers other healthcare products and services, including subscriptions, pharma manufacturer solutions, and telehealth services. By serving both consumers and pharmacy benefit managers, GoodRx facilitates transparency and efficiency in prescription drug transactions, aiming to make healthcare more affordable and accessible.
Is GDRX stock a good buy?
GDRX stock presents a mixed investment profile. The company's strong gross margin of 91.0% and established brand recognition are positive indicators. However, the relatively low profit margin of 4.0% and a market cap of $0.83B suggest potential limitations. The company's growth opportunities in telehealth and pharma partnerships could drive future value. Investors should consider the competitive landscape and regulatory risks before investing. A balanced analysis of valuation metrics, growth potential, and risk factors is essential to determine if GDRX is a suitable investment.
What are the main risks for GDRX?
The main risks for GoodRx include increased competition from other price comparison platforms, changes in pharmacy benefit manager (PBM) practices, and regulatory scrutiny of prescription drug pricing. The company's reliance on pharmacy partnerships also poses a risk, as changes in these relationships could impact revenue. Additionally, an economic downturn could affect consumer spending on healthcare, reducing demand for GoodRx's services. Investors should carefully consider these risks before investing in GDRX.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Data provided for informational purposes only.